Document:

fs1a2ex10xxvii_chinabct.htm

Exhibit 10.27

 

Shares Pledge Agreement

Party A: Guangxi Liuzhou Baicaotang Medicine Ltd.

Legal Representative: Tang Huitian, President.

 

Party B: Liuzhou Baicaotang Property Management Co., Ltd

Legal Representative: Tan Yuqing

Whereas, Party B borrowed RMB1,377,000 Yuan from Party A on 02/25/2009.

Through the friendly negotiation, Party A and Party B hereby, with respect to the issue that Party B pledgesits further 51% of the shares by 1,377,000 it owns inthe Liuzhou Baicaotang Pharmaceutical Chain Co., Ltd to Party A, have reached the following agreements:

Article 1  Right of Credits

Party A lent RMB Yuan to Party B on 02/25/2009.

 

Article 2  Repayment Period

Party B shall pay all the amount of loans to Party A no later than 12/31/2015.

Article 3  Pledged Shares

Party B agrees to pledge further 51% of the shares it owns inthe Liuzhou Baicaotang Pharmaceutical Chain Co., Ltd to Party A., and will deliver the shares certificate which represents further 51% of the shares by 1,377,000 of Liuzhou Baicaotang Pharmaceutical Chain Co., Ltd to Party A before 03/31/2009.

Article 4  Scope of the Guaranty of Pledge

The scope of the guaranty of pledge provided by Party B includes: 1) Loan principal;2) Interest (as calculated by the loan rate of fluid capital of the corresponding period issued by People’s Bank of China); 3) Liquidated damage; 4) Legal fees, attorney fees, travel and other necessary expenses paid or advanced by Party A for claims.

Article 5  Ownership of Pledge Interest

Party A and Party B hereby agree that the pledge interest during the pledge period will be possessed by Party A.

Article 6  Fulfillment of Liabilities

If Party B repays the debt according to the stipulations of Article 1 and Article 2 herein, Party A will return all the pledged shares to Party B within five days from the date of Party B’s full repayment to Party A, and complete the deregistration procedures of such pledge.

If Party B fails to repay the debt according to the stipulations of Article 1 and Article 2 herein, Party A is entitled to ask Party B to take all the repayment liability within the scope of the guaranty of pledge set forth in Article 4 herein. If the value of the pledged shares is not enough to cover the debt, any balance due shall be recoverable from Party B. 

 

  

  

  

 

Party A may use the money from converting, auction or sale of the pledged sharesto pay off the debtsthrough the negotiation with Party B, where the money from the converting, auction or sale of the pledged shares is excess the amount of debt, the excess amount will belong to Party B, where the money is not enough to cover the amount of debt, any balance due shall be recoverable from Party B.

If Party B fails to fulfill the repayment obligations within the scope of the guaranty of pledge, or the value of the pledged shares is not enough to cover the debt and Party B fails to repay the debt accordingly, Party B will have no right to redeem the pledged shares.

Article 7  Registration of Pledge

Party B is responsible for completing the registration of shares pledge within ten days from the execution date of this agreement, and will inform Party A of the registration in writing. Party B will have no right to transfer the pledged shares in whole or in part during the pledge period.

Article 8  Miscellaneous

Any dispute arising out of the performance of this agreement, shall be settled through mutual consultation by Party A and Party B. If no agreement is reached through the consultation, such dispute will be submitted to Liunan District People's Court located in Liuzhou for judgement.

This agreement is made in five counterparts with each party holding two copies, and the other one copy will be submitted to Liuzhou Baicaotang Pharmaceutical Chain Co., Ltd for shares pledge filing. This agreement will be signed and sealed by Party A and Party B, and will become effective from the date that the pledged shares registered in the shareholders roster of Liuzhou Baicaotang Pharmaceutical Chain Co., Ltd.

This agreement may be modified or amended only by written confirmation duly signed by Party A and Party B.

	
Party A: Guangxi Liuzhou

Baicaotang Medicine Ltd.

	
Party B: Liuzhou Baicaotang Property Management Co., Ltd

	
 

 

Legal Representative:/s/ Hui Tian Tang

	
 

 

Legal Representative:/s/Tan Yuqing

 

	
Date: 03/31/2009

	
Date: 03/31/2009fs1a2ex10viii_chinabct.htm

Exhibit 10.28

 

Termination Agreement

 

Party A:    Guangxi Liuzhou Baicaotang Medicine Ltd.

 

Legal Representative: Tang Huitian

 

Party B:    Shareholders of Liuzhou Baicaotang Property Management Ltd.

 

Representative: Tang Huitian

 

 

Party C:    Liuzhou Baicaotang Property Management Ltd.

 

Legal Representative: Tan Yuqing

 

 

Whereas,

 

(1)           Party A and Party B entered into a Shares Pledge Agreement on May 3, 2008 and another Shares Pledge Agreement on March 31, 2009 to pledge Party B’s equities in Party C to secure the loans that Party B has borrowed from Party A (the “ Loan ”);

 

(2)           Party A and Party B have found that they have entered into the two Shares Pledge Agreements in error and intend to correct it.

 

 

Party A, Party B and Party C hereby enter into the following agreement:

 

 

1.           Party A and Party B agree to terminate the two Shares Pledge Agreements that were signed respectively on May 3, 2008 and March 31, 2009.

 

2.           Party C agrees to undertake to secure the Loan.  Party A, Party B and Party C confirm that the agreements that Party C has entered into with Party A to pledge all the equities it holds in Guangxi Liuzhou Baicaotang Medicine Retail Co., Ltd. remain in full force and effect.

 

3.           Any dispute arising out of the performance of this agreement shall be negotiated between the parties.  When failing to get a consistent settlement, any party may submit such dispute to the People’s Court of Liunan District, Liu Zhou City for determination.

 

4.           The terms and conditions set forth in herein should not be modified unless written agreed by the parties.

 

  

  

  

 

5.           This agreement is made in six counterparts with each party holding two copies.  This agreement shall become binding on the date signed by the parties.

 

Party A: Guangxi Liuzhou Baicaotang Medicine Ltd.

 

Legal Representative:/s/ Hui Tian Tang

 

Date: March 2, 2010

 

 

Party B: Shareholders of Liuzhou Baicaotang Property Management Co., Ltd

 

Representative:/s/ Hui Tian Tang

 

Date: March 2, 2010

 

 

Party C: Liuzhou Baicaotang Property Management Ltd.

 

Legal Representative:/s/: Tan Yuqing

 

Date: March 2, 2010fs1a2ex10xlviii_chinabct.htm

Exhibit 10.48

 

Sales Agreement

Party A: Guangxi Liuzhou Baicaotang Medicine Co., Ltd.

Party B: Liuzhou Baicaotang, Guigang Subsidiary Co.

Through the negotiations of the parties, parties reached the following agreement regarding the sales related issues:

1. Party B is Party A’s VIP customer, Party A will be responsible for all supplies of Party B and Party A is responsible for the delivery of the products.

2.Party B will be responsible for all the delivery right of Party A in the Guigang District.

3. Party A guarantees that the products delivered to Party B will meet the following requirements:

i. All products are legal and will meet the quality requirements.

ii. All packages of the products are procured through legal channel and the label will meet the legal requirements.

iii. The Chinese Medicine shall be marked with the place of production.

4. Party A shall be responsible for the quality of the products supplied to Party B; Party A shall be responsible for all the consequences caused by the product quality.

5. The pricse of the products shall be determined by market, the parties shall negotiate the price of the products.

6. There are two copies of the agreement, each party will hold one copy with equal legal force.

Party A:  Guangxi Liuzhou Baicaotang Medicine Co., Ltd.

Legal representative: /s/ Gouzhuang Rong

Date: 1/1/2009

Party B: Liuzhou Baicaotang, Guigang Subsidiary Co.

Legal representative: /s/  Shenghu Tang

Date: 1/1/2009fs1a2ex10lv_chinabct.htm

Exhibit 10.55

 

CHINA BCT PHARMACY GROUP, INC.

 

2010 OMNIBUS SECURITIES AND INCENTIVE PLAN

 

 STOCK OPTION AGREEMENT

 

DIRECTOR NON-QUALIFIED STOCK OPTION

 

THIS AGREEMENT made as of July 16, 2010, by and between China BCT Pharmacy Group, Inc., a Delaware corporation (the “Company”), and Eng Leong Lee (the “Optionee”).

 

WITNESSETH:

 

WHEREAS, the Company has adopted the China BCT Pharmacy Group, Inc. 2010 Omnibus Securities and Incentive Plan (the “Plan”) for the benefit of its employees, nonemployee directors and consultants and the employees, nonemployee directors and consultants of its affiliates, and

 

WHEREAS, the Committee has authorized the grant to the Optionee of an Option under the Plan, on the terms and conditions set forth in the Plan and as hereinafter provided,

 

NOW, THEREFORE, in consideration of the premises contained herein, the Company and the Optionee hereby agree as follows:

 

1.     Definitions.

 

Terms used in this Agreement which are defined in the Plan shall have the same meaning as set forth in the Plan.

 

        2.   Grant of Option.

 

The Committee hereby grants to the Optionee an option to purchase 10,000 shares of the Company’s Common Stock (“Shares”) for an Option price per Share equal to $4.00 (not less than the Fair Market Value of a Share on the date of the grant of the Option) (the “Option”).

 

3.   Option Terms and Exercise Period.

 

(a)    The Option shall be exercised, and payment by the Optionee of the Option price shall be made, pursuant to the terms of the Plan.

 

(b)    All or any part of the Option may be exercised by the Optionee no later than the tenth (10th) anniversary of the date of this Agreement.

 

(c)    This Agreement and the Option shall terminate on the earlier of (i) the fifth (5th) anniversary of the date of this Agreement or (ii) the date the Option is fully exercised.

 

 

  

  

  

 

        4.   Vesting.

 

                                Subject to Section 10, the Option shall vest and become exercisable on June 6, 2011.

 

                5.             Termination of Director Status.

 

                                Sections 6.2 and 6.4 of the Plan shall control.

 

6.             Restrictions on Transfer of Option.

 

This Agreement and the Option shall not be transferable otherwise than (a) by will or by the laws of descent and distribution or (b) by gift to any Family Member of the Optionee, and the Option shall be exercisable, during the Optionee’s lifetime, solely by the Optionee, except on account of the Optionee’s Permanent and Total Disability or death, and solely by the transferee in the case of a transfer by gift to a Family Member of the Optionee.

 

        7.         Exercise of Option.

 

(a)    The Option shall become exercisable at such time as shall be provided herein or in the Plan and shall be exercisable by written notice of such exercise, in the form prescribed by the Committee, to the Secretary of the Company, at its principal office. The notice shall specify the number of Shares for which the Option is being exercised.

 

(b)    Shares purchased pursuant to the Option shall be paid for in full at the time of such purchase in cash, in Shares, including Shares acquired pursuant to the Plan, or part in cash and part in Shares. Shares transferred in payment of the Option price shall be valued as of the date of transfer based on their Fair Market Value.

 

        8.             Regulation by the Committee.

 

This Agreement and the Option shall be subject to any administrative procedures and rules as the Committee shall adopt. All decisions of the Committee upon any question arising under the Plan or under this Agreement, shall be conclusive and binding upon the Optionee and any person or persons to whom any portion of the Option has been transferred by will, by the laws of descent and distribution or by gift to a Family Member of the Optionee.

 

    9.             Rights as a Stockholder.

 

The Optionee shall have no rights as a stockholder with respect to Shares subject to the Option until certificates for Shares of Common Stock are issued to the Optionee.

 

              10.             Change of Control.

 

Notwithstanding the vesting requirements contained in Section 4, upon a Change  of Control, the Option shall automatically become fully vested and exercisable as of the date of such Change of Control.

 

 

  

2

  

  11.             Reservation of Shares.

 

With respect to the Option, the Company hereby agrees to at all times reserve for issuance and/or delivery upon payment by the Optionee of the Option price, such number of Shares as shall be required for issuance and/or delivery upon such payment pursuant to the Option.

 

  12.             Delivery of Share Certificates.

 

Within a reasonable time after the exercise of the Option the Company shall cause to be delivered to the Optionee, his or her legal representative or his or her beneficiary, a certificate for the Shares purchased pursuant to the exercise of the Option.

 

  13.             Amendment.

 

The Committee may amend this Agreement at any time and from time to time; provided, however, that no amendment of this Agreement that would materially and adversely impair the Optionee’s rights or entitlements with respect to the Option shall be effective without the prior written consent of the Optionee.

 

  14.             Plan Terms.

 

The terms of the Plan are hereby incorporated herein by reference.

 

  15.             Effective Date of Grant.

 

The Option shall be effective as of the date first written above.

  

3

  

 

              16.             Optionee Acknowledgment.

 

By executing this Agreement, the Optionee hereby acknowledges that he or she has received and read the Plan and this Agreement and that he or she agrees to be bound by all of the terms of both the Plan and this Agreement.

 

	
ATTEST:

	  	
CHINA BCT PHARMACY GROUP, INC.

	  	  	  	  
	
_______________________

	  	
By: /s/ Hui Tian Tang

Its: Chief Executive Officer

 

/s/ Eng Leong Lee , Optionee

	  

 

 

 

 

 4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00176-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00176-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00176-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00176-of-00352.parquet"}]]